Metropolitan Life Insurance Company (MetLife)’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,870
| Closed | -$54.2K | – | 1649 |
|
|
2024
Q1 | $54.2K | Sell |
2,870
-425
| -13% | -$8.02K | ﹤0.01% | 1366 |
|
|
2023
Q4 | $62.9K | Hold |
3,295
| – | – | ﹤0.01% | 1320 |
|
|
2023
Q3 | $59.1K | Buy |
3,295
+514
| +18% | +$9.23K | ﹤0.01% | 1308 |
|
|
2023
Q2 | $56.5K | Hold |
2,781
| – | – | ﹤0.01% | 1351 |
|
|
2023
Q1 | $50.7K | Sell |
2,781
-358
| -11% | -$6.53K | ﹤0.01% | 1384 |
|
|
2022
Q4 | $64.9K | Buy |
3,139
+143
| +5% | +$2.96K | ﹤0.01% | 1317 |
|
|
2022
Q3 | $78.4K | Hold |
2,996
| – | – | ﹤0.01% | 1167 |
|
|
2022
Q2 | $75.9K | Hold |
2,996
| – | – | ﹤0.01% | 1231 |
|
|
2022
Q1 | $94.6K | Sell |
2,996
-9,127
| -75% | -$288K | ﹤0.01% | 1230 |
|
|
2021
Q4 | $491K | Hold |
12,123
| – | – | 0.01% | 1443 |
|
|
2021
Q3 | $423K | Hold |
12,123
| – | – | 0.01% | 1574 |
|
|
2021
Q2 | $333K | Buy |
12,123
+846
| +8% | +$23.2K | ﹤0.01% | 1779 |
|
|
2021
Q1 | $317K | Sell |
11,277
-530
| -4% | -$14.9K | ﹤0.01% | 1718 |
|
|
2020
Q4 | $307K | Hold |
11,807
| – | – | ﹤0.01% | 1667 |
|
|
2020
Q3 | $202K | Buy |
11,807
+361
| +3% | +$6.19K | ﹤0.01% | 1767 |
|
|
2020
Q2 | $283K | Buy |
11,446
+276
| +2% | +$6.83K | 0.01% | 1581 |
|
|
2020
Q1 | $155K | Buy |
11,170
+1,255
| +13% | +$17.4K | ﹤0.01% | 1746 |
|
|
2019
Q4 | $100K | Sell |
9,915
-1,631
| -14% | -$16.5K | ﹤0.01% | 2333 |
|
|
2019
Q3 | $105K | Hold |
11,546
| – | – | ﹤0.01% | 2277 |
|
|
2019
Q2 | $91.8K | Buy |
11,546
+1,421
| +14% | +$11.3K | ﹤0.01% | 2347 |
|
|
2019
Q1 | $126K | Sell |
10,125
-1,334
| -12% | -$16.7K | ﹤0.01% | 2182 |
|
|
2018
Q4 | $123K | Buy |
+11,459
| New | +$123K | ﹤0.01% | 2134 |
|